South Korea biosimilar market analysis: Trends, Drivers, and Growth Opportunities 2025-2033
The South Korea biosimilar market growth was valued at USD 505.1 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 3,513.2 Million by 2033, exhibiting a (CAGR) of 24.05% from 2025-2033.